NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 20, 2026 $3.90 -3.43% $4.15 X 94.01% 0
Feb 20, 2026 $3.95 -2.14% $4.15 X 95.26% 0
Feb 20, 2026 Bullish $4.15 V 1
Feb 19, 2026 $3.65 -3.57% $4.04 X 90.46% 0
Feb 19, 2026 $3.71 -2.23% $4.04 X 91.72% 0
Feb 19, 2026 Bullish $4.04 V 1
Feb 11, 2026 $3.60 -4.18% $3.67 V 98.17% 1
Feb 11, 2026 $3.86 +2.61% $3.67 X 94.87% 0
Feb 11, 2026 Bullish $3.67 X 0
Feb 4, 2026 Bullish $3.82 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE